Applicability of the Acai Fruit (Euterpe Oleracea) Dye for Chromovitrectomy in Humans
NCT02691429 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2017-06-07
Summary
Our research group tested the toxicity of different dye concentrations extracted from the acai fruit using a rabbit model. The dye extracted from the acai fruit in concentrations of 10% and 25% was found to be safe for vitreoretinal surgery. This initial research represented the landmark research for testing this alternative vital dye in a clinical research in humans.
The aim of the present clinical trial in humans will be to test the applicability of the acai dye in the identification of the posterior hyaloid and ILM during vitreoretinal surgery in humans.
Conditions
- Epiretinal Membrane
- Macular Hole
- Diabetic Retinopathy
Interventions
- OTHER
-
Acai dye 10%
dye to be used during chromovitrectomy in humans
Sponsors & Collaborators
-
Rafael R. Caiado
collaborator UNKNOWN -
Casa de Saúde São José
collaborator OTHER -
Acácio Alves Souza Lima-Filho
collaborator UNKNOWN -
Eduardo Novais
collaborator UNKNOWN -
Emmerson Badaró
collaborator UNKNOWN -
André Maia
collaborator UNKNOWN -
Rita Sinigaglia-Coimbra
collaborator UNKNOWN -
Sung Eun S. Watanabe
collaborator UNKNOWN -
Eduardo B. Rodrigues
collaborator UNKNOWN -
Michel Eid Farah
collaborator UNKNOWN -
Mauricio Maia
collaborator UNKNOWN -
Federal University of São Paulo
lead OTHER
Principal Investigators
-
Mauricio Maia · Federal University of São Paulo UNIFESP
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-02-29
- Primary Completion
- 2016-11-30
- Completion
- 2017-05-31
Countries
- Brazil
Study Locations
More Related Trials
-
The Safety Outcomes of 27 Gauge Vitrectomy for Posterior Segment Disease in High Myopia
NCT04360603 ·Status: UNKNOWN ·Phase: NA
-
Surgical Removal of Idiopathic Epiretinal Membrane With and Without the Assistance of Indocyanine Green.
NCT00376857 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Higher Cutting Rate in Microincision Vitrectomy for Proliferative Diabetic Retinopathy
NCT02464800 ·Status: COMPLETED
-
Changes in the Diameter of Retinal Vessels After Remote Ischemic Conditioning
NCT02898480 ·Status: COMPLETED ·Phase: NA
-
Surgical Outcomes for Proliferative Diabetic Retinopathy by Preoperative Glycemic Control and Renal Function
NCT03522311 ·Status: COMPLETED
-
Transconjunctival Sutureless 25-Gauge Vitrectomy
NCT00870597 ·Status: COMPLETED ·Phase: PHASE3
-
Inverted Internal Limiting Membrane Flap Technique for Macular Hole Retinal Detachment in Highly Myopic Eyes
NCT02896972 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Double Staining With Brilliant Blue G for Macular Surgery
NCT01820520 ·Status: TERMINATED ·Phase: PHASE3
-
Effect of the Membrane Blue Dual® Dye on the Retinal Sensitivity in Macular Hole Surgery
NCT02894424 ·Status: COMPLETED
-
Mechanical Properties of the Internal Limiting Membrane and Intraoperative Utility of Brilliant Blue g (Bbg) and Indocyanine Green (Icg) Assisted Chromovitrectomy
NCT01485575 ·Status: RECRUITING
-
Scleral Self-indentation Chandelier-assisted Peripheral Vitrectomy Under Air Rhegmatogenous Retinal Detachment.
NCT03218371 ·Status: COMPLETED
-
Cryotherapy of Sclerotomy Sites for Prevention of Late Postvitrectomy Diabetic Hemorrhage
NCT00370409 ·Status: COMPLETED ·Phase: NA
-
Vitrectomy Retinal Oxygenation
NCT01510691 ·Status: WITHDRAWN
-
Vitrectomy and Scleral Shortening for Macular Hole Retinal Detachment or Myopic Traction Maculopathy
NCT02528045 ·Status: COMPLETED
-
Surgical Outcome of Vitrectomy for Myopic Traction Maculopathy in Highly Myopic Eyes
NCT01658761 ·Status: COMPLETED ·Phase: NA
-
Management of Deep Retinal Capillary Ischemia by Electromagnetic Stimulation and Platelet- Rich Plasma
NCT04242719 ·Status: COMPLETED ·Phase: NA
-
Corneal Changes After Retinal Surgery
NCT01446367 ·Status: COMPLETED
-
Evaluation of Vitrectomy With ILM Peeling in Myopic Macular Hole With Only Posterior Retinal Detachment
NCT06194760 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Treatment of Retinal Detachment in People Who Have Not Had Cataract Surgery With Vitrectomy vs Vitrectomy and Cataract Removal
NCT06997874 ·Status: RECRUITING ·Phase: PHASE3
-
Evaluation of Visual Functions After Pars Plana Vitrectomy With and Without Internal Limiting Membrane Peeling in RRD
NCT04139811 ·Status: COMPLETED ·Phase: NA
-
Intravitreal Long Acting Gas in the Prevention of Early Postoperative Vitreous Hemorrhage in Diabetic Vitrectomy
NCT00155454 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Evaluation of Two Different Brilliant Blue G Dyes as Staining Agent in Vitreo Retinal Surgery.
NCT05086588 ·Status: COMPLETED
-
Ultrastructure Analysis of Excised Internal Limiting Membrane in Eyes of Highly Myopia With Myopic Traction Maculopathy
NCT02528058 ·Status: COMPLETED
-
Internal Limiting Membrane Peeling in Proliferative Diabetic Retinopathy
NCT04380064 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Assessment of Retinal Vascular Changes With and Without ILM Peeling in Diabetic Vitrectomy Using OCT-A.
NCT05739539 ·Status: COMPLETED ·Phase: NA